Monday, April 1, 2019

Global Vaccines Market Worth Over $33 Billion in 2019

Global Vaccines Market Worth Over $33 Billion in 2019
Vaccines Market
The global vaccines market size to be around $33 billion to $36 billion as of 2018 and projects the opportunities to grow at a CAGR of around 8% to 10% during the forecast period 2019 to 2025.

Global Vaccines Market: Demand Analysis and Growth Forecast

The upsurge in the prevalence of infectious diseases such as polio, measles, and viral hepatitis caused by fungi and bacteria can be significantly curtailed by providing proper vaccination, which also ensures maintaining sustainable health throughout the lifetime. Vaccinations play a major role to strengthen the immune system during the lifespan of an individual. The growing focus of people and government initiatives on immunization programs for a safe and secure life and production of technologically advanced vaccines will drive the growth of vaccines the market, according to the analyst of a recent business intelligence study from IndustryARC. The report evaluates the global vaccines market size to be around $33 billion to $36 billion as of 2018 and projects the opportunities to grow at a CAGR of around 8% to 10% during the forecast period 2019 to 2025. The IndustryARC report is titled as “Vaccines Market: By Type (Monovalent, Multivalent); By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Others); By Disease Indication (Pneumococcal Disease, DTP, Others); By End User (Paediatrics, Adults) & Region – Forecast (2019 - 2025).”

View Full Table of Contents of Vaccines Market :

https://industryarc.com/Report/17004/vaccines-market.html

Global Vaccines Market: Leading Segments

The analyst of the report identifies that North America held the major share in the vaccines market and was around 34% to 36%.  North America’s dominance is due to the robust healthcare infrastructure in the U.S. and Canada as well as the presence of a number of research and development facilities. Moreover, the major demand share in this region is also ascribed to deep-rooted vaccination programs, growing pervasiveness of diseases, and embracing adoptions of progressive vaccines. According to the Immunization 317 Coalition in the USA, increasing the federal funding for disease control and prevention is paramount. Section 317 provides safety programs for underinsured adult’s population who have no other alternative to recompenses for vaccination.

Inactivated vaccines are the key application in the vaccines market as per the new findings of the IndustryARC, and this application is projected to grow at a CAGR of around 8% to 9% during the forecast period of 2019 to 2025. Growing usage of inactivated vaccines to protect against various diseases such as flu, rabies, and polio will propel the growth of the market. According to The United Nations International Children's Emergency Fund, the need for the inactivated polio vaccines for immunization is 65 million doses. On the other hand, the availability of prequalified inactivated polio vaccines in 2019 is 71 million doses, out of which 64 million are essential for immunization needs. This availability of the inactivated vaccines for the prevention of various diseases will fuel the vaccines market in the near future.

Vaccines Market Trends

Innovations in Vaccine Delivery Systems

•    Escalating demand for vaccine delivery systems such as micellar delivery systems, polymeric nanoparticle delivery systems, emulsion-type vaccine delivery systems, liposomal delivery systems, and immune-stimulating complexes (ISCOMs), and needle-free technologies are developed to induce vaccines into the human body through different routes. These delivery systems will enable the reduction in the number of doses of vaccine at the injection site. Moreover, microscopic nanoparticles act as the transport mechanism for antigens in order to deliver them directly to immune cells.

The modular approach to Vaccine Production for robust immunity

•    The innovative Multiple Antigen Presenting System (MAPS) modular method enables the efficient production of vaccines which offers robust immunological and technical advantages. Additionally, this method develops vaccines for pathogens including pneumococcus and tuberculosis for a strong immune response in our body.

•    Emergent BioSolutions Completes Acquisition with PaxVax to advance the pipeline with vaccines in order to address acute respiratory diseases and viral spread disease chikungunya. This acquisition resulted in the development and manufacturing of specialty vaccines such as Vivotif oral vaccine and Vaxchora for the prevention of emerging infectious diseases.

Vaccines Market: Competitive Landscape

Some of the key players operating in vaccines market are: Merck &Co., Inc., Emergent Bio Solutions, Inc., Johnson and Johnson, Sanofi Pasteur, Inc., Pfizer, Inc., Novartis AG, CSL Ltd., GlaxoSmithKline Plc, Abbott Laboratories, Inc., AstraZeneca Plc, Janssen Pharmaceuticals, Inc

 

Talk to one of our sales representative about the full report by providing your details in the link below:

https://industryarc.com/support.php?id=17004

 

Related Reports

Therapeutic Vaccine Market

https://industryarc.com/Report/16292/therapeutic-vaccine-market.html

DNA Vaccines Market

https://industryarc.com/Report/16032/dna-vaccines-market.html

 

What can you expect from the report?

The Vaccines Market is Prepared with the Main Agenda to Cover the following 20 points:

1. Vaccines Market Size by Product Categories & Application        

2. Vaccines Market trends & Relevant Market Data

3. Manufacturer Landscape                                  

4. Distributor Landscape                                   

5. Pricing Analysis                                       

6. Top 10 End-user Analysis                               

7. Product Benchmarking                                   

8. Product Developments                                   

9. Mergers & Acquisition Analysis                           

10. Patent Analysis

11. Vaccines Market Demand Analysis (Revenue & Volume)

12. Country-level Analysis

13. Competitor Analysis

14. Vaccines Market  Shares Analysis

15. Value Chain Analysis

16. Vaccines Market Supply Chain Analysis

17. Vaccines Market Strategic Analysis

18. Vaccines Market Current & Future Market Landscape Analysis

19. Vaccines Market Opportunity Analysis

20. Vaccines Market Revenue and Volume Analysis

 

Frequently Asked Questions:

Q. Does IndustryARC provide customized reports and charge additionally for limited customization?

Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:

1. Increase the level of data in the application or end-user industry.

2. Increase the number of countries in geography chapter.

3. Find out market shares for other smaller companies or companies which are of interest to you.

4. Company profiles can be requested based on your interest.

5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end-use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com  to discuss more about our consulting services.

About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.

Media Contact
Company Name: IndustryARC
Contact Person: Mr. Venkat Reddy
Email:Send Email
Phone: 1-614-588-8538 (Ext: 101)
Address:Madhapur
City: Hyderabad
Country: India
Website: http://industryarc.com/